Strategic Partnerships Marius Pharmaceuticals has actively pursued licensing and distribution agreements with Hikma for Canada and collaborations with Hims & Hers, plus a YouGov market survey partnership. This indicates a strong openness to channel and digital health partnerships that can be leveraged to expand sales of KYZATREX and related therapies in new regions and platforms.

Regional Expansion With Canada imminent launch of KYZATREX following Health Canada approval and partnerships aimed at education and access, there is a clear opportunity to target North American clinicians, specialty pharmacies, and telehealth platforms to drive accelerated adoption and payer engagement.

Digital Outreach Active use of digital health platforms and a focus on patient education initiatives like ReThink Testosterone, along with a new corporate website, positions Marius to leverage direct-to-patient campaigns, digital marketing collaborations, and provider education programs to grow demand for testosterone therapies.

Market Education YouGov research unveiling gaps in awareness and delayed care in men's health creates a sales angle for awareness campaigns and provider training programs that can drive early diagnosis and treatment uptake, supported by partnerships and payer-focused materials.

Financial Readiness Current revenue range and a substantial funding runway suggest capacity for co-promotion, market expansion, and sponsored studies or real-world evidence initiatives that can reassure payers and providers, enabling scalable adoption of KYZATREX in new markets.